MUSCAT : The Center, represented by the Breast Unit in the Department of Radiology and Nuclear Medicine, launched a new service for diagnosing breast cancer through magnetic resonance imaging-guided biopsy.

The technology provides a high level of accuracy for diagnosing cases, assessing risks, and determining the appropriate treatment plan for patients. It takes tissue samples of breast masses guided by magnetic resonance images to locate suspicious tissues and extract samples accurately in order to verify whether they are cancerous or not – which are usually invisible in mammograms, ultrasound images, or any other examination of the breast.

The introduction of MRI-guided biopsy technology in the Sultanate of Oman will contribute to early detection of breast cancer in groups most at risk of the disease, especially those who need to undergo regular breast MRI program due to the presence of a strong family history of cancer, or the presence of genetic genes that increase the possibility of cancer or other conditions. This technology can detect subtle changes in the breast early.

Breast cancer is among the most common cancers among women globally and locally, and according to the Ministry of Health report for the year 2019, the rate of diagnosed cases of breast cancer in the third and fourth stages reached 31 percent. The presence of such advanced technology will contribute to increasing the rates of early detection of cancer and improving the chances of recovery from the disease.

For all the latest news from Oman and GCC, follow us on Twitter, Instagram and LinkedIn, like us on Facebook and subscribe to our YouTube page, which is updated daily.